Clinical trial Recruiting at 1 site Interventional Ages 38 to 55 Women only

Nutritional supplement to change body composition in women during perimenopause

Official title: A Pilot Study Investigating the Effects of a Nutritional Supplement on Physiological and Metabolic Markers in 38-55-year-old Females

Run by University of Southampton · NCT07615777 · Data updated 2026-11-12

A 12-week test of a supplement containing myo-inositol, berberine, cinnamon, and chromium to see if it changes body fat and other metabolic markers in women aged 38-55 compared with a placebo.

More Body Composition trials

Quick facts

Study typeInterventional
Ages38 Years to 55 Years
SexWomen only
Enrollment80 (estimated)
SponsorUniversity of Southampton
Academic / other
Drugs / interventionsradiation
Locations1 site (Southampton, Hampshire)
StatusRecruiting
StartedJuly 9, 2026
Main results expectedDecember 2027
Study endsDecember 2027
Registry record updatedOctober 21, 2026
Trial IDNCT07615777 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 38-55 who have irregular menstrual cycles or menopausal symptoms and are willing to avoid other supplements during the study.

Probably not a fit

Individuals with diabetes, very low BMI, recent cancer, or other listed exclusions may not experience benefit and could be at higher risk if enrolled.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study tests whether a 12-week nutritional supplement can alter body composition and related metabolic markers in perimenopausal women aged 38-55. Participants will be randomized to receive either the supplement or a placebo, with outcomes including body mass index, body fat composition, plasma and urine metabolites, menopausal symptoms, and physical performance measures like grip strength. The trial uses standard randomized, placebo-controlled design to compare changes between groups over the 12 weeks. Eligible participants are women 38-55 with irregular cycles or menopausal symptoms, not taking other supplements, and without certain exclusion conditions. Primary aim is to determine if the supplement produces meaningful changes in body composition relative to placebo.

Why it matters

Potential benefit: If successful, participants may experience favorable changes in body composition and related metabolic and symptom measures.

How similar studies have gone: Similar multi-ingredient nutritional approaches have shown signals in metabolic and body composition outcomes in related populations, but results are variable and often not definitive.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Assigned sex at birth is female
* Aged 38-55 years
* Experiencing irregular menstrual cycles but not amenorrheic for more than 12 months or have at least one of the following recent symptoms (i.e., from 38 years onwards): (1) hot flushes, (2) sleep disturbances, (3) mood swings, (4) concentration difficulties, (5) bloating or (6) weight gain.

  * Willing to avoid taking other food supplements during the study period
  * Able to provide written informed consent

Exclusion Criteria:

* Diabetes
* BMI \<18.5 kg/m2
* Pregnant or trying to get pregnant
* No active cancer or cancer within last 5 years
* Total Hysterectomy
* Known allergies to cinnamon extract, chromium, berberine, myo-inositol
* Currently taking part in research, or have done within the last 3 months
* Diagnosed autoimmune diseases
* Diagnosed hypoglycemia

Where it's running

  • NIHR Southampton Clinical Research Facility
    Southampton, Hampshire, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.